Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.

Abbott today announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation, and for the purchase from all holders, wherever resident, of CFR’s outstanding American Depositary Shares. The offer was not conditioned on the receipt of any minimum number of ordinary shares or American Depositary Shares being tendered.

The offer expired at 5 p.m., New York City time, on Sept. 23, 2014, and was not extended. A Chilean tender offer for CFR ordinary shares, which was made concurrently with the U.S. offer, expired at 5:30 p.m., Chilean time, on Sept. 23, 2014, and was not extended. The results of the U.S. offer will be announced on Sept. 26, 2014, at the time the results of the Chilean tender offer for CFR ordinary shares are announced.